Enanta Pharmaceuticals Cash Flow Statement (2012-2026) | ENTA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-24.02M-81.90M-30.11M-33.59M-31.70M-26.35M-28.99M-37.66M-39.06M-28.11M-33.41M-31.16M-22.66M-28.63M-22.29M-22.64M-18.25M-18.70M-11.94M-13.09M
Share-based Compensation (Quarter)
5.47M5.35M6.06M6.47M7.60M6.83M7.14M7.36M7.00M6.72M8.10M5.56M5.42M7.72M5.67M4.69M4.18M4.03M3.81M3.75M
Deferred Taxes (Quarter)
Gains from Sales and Divestitures (Quarter)
0.04M0.04M0.03M0.03M0.03M0.01M0.06M0.06M0.07M0.07M0.12M0.12M0.14M0.07M0.15M
Gains from Investment Securities (Quarter)
3.88M0.26M15.56M0.10M4.02M-0.62M0.82M0.17M4.46M-3.47M1.09M1.20M0.48M-23.68M0.02M0.04M1.18M-1.18M1.27M
Non-cash Items (Quarter)
17.65M49.17M2.42M83.00M2.54M28.78M17.65M2.80M2.92M3.03M9.27M4.19M1.42M3.46M0.09M6.46M3.99M4.25M
Cash from Operations (Quarter)
-29.51M-21.02M-13.27M-26.38M-29.60M-15.53M-35.64M-13.78M-32.13M-21.60M-24.99M-28.60M-14.78M-10.40M-16.80M-13.49M17.51M-6.49M-11.70M-7.16M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.56M-0.60M-0.55M-0.38M-0.19M-0.05M0.34M1.01M1.45M0.06M-0.27M-0.03M0.23M1.20M-0.63M-0.82M-0.01M0.96M-0.02M-0.30M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.82M0.81M0.78M0.82M0.72M0.66M0.51M0.54M0.65M0.67M0.64M0.62M0.59M0.48M0.89M1.20M1.21M1.28M1.23M1.21M
Change in Working Capital
Change in Receivables (Quarter)
1.49M1.95M4.07M-8.93M0.76M0.84M2.27M-4.79M1.10M-10.28M-0.44M-0.42M0.42M-1.53M1.07M-0.93M1.54M-1.45M1.61M-0.68M
Change in Account Payables (Quarter)
0.18M3.58M-1.66M-1.81M-5.08M3.92M-0.69M6.65M-3.28M-3.83M5.17M-4.91M0.86M-1.54M-0.17M0.87M-1.29M-0.72M-0.06M2.48M
Change in Accured Expenses (Quarter)
1.97M4.68M4.21M-5.01M-2.44M1.78M-6.60M0.55M2.70M0.79M-6.74M-0.97M1.66M0.40M-2.91M-1.97M2.52M2.42M-5.18M-0.72M
Change in Taxes (Quarter)
17.53M6.68M-8.50M-0.00M-0.02M-0.01M-0.01M0.07M-2.86M5.09M0.73M0.30M0.42M-0.46M0.45M1.39M-33.81M65.76M0.02M
Other Working Capital Changes (Quarter)
-9.79M3.82M-1.46M1.35M-3.12M2.49M-0.72M0.58M0.11M0.24M-0.02M-2.12M4.13M-2.43M-1.73M0.27M0.31M-0.15M0.25M0.26M
Investing Activities
Capital Expenditures (Quarter)
-0.30M0.73M0.05M0.39M0.25M0.53M3.16M2.38M2.15M1.37M0.79M1.67M3.96M11.53M8.74M2.54M-9.89M11.50M0.14M0.01M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)
93.06M72.11M108.77M26.75M54.55M38.40M104.10M72.40M33.05M119.32M134.51M125.58M95.35M28.02M77.65M53.19M59.66M72.38M101.47M53.91M
Cash from Investing Activities (Quarter)
-43.70M72.68M45.50M-35.05M16.22M28.23M33.57M46.77M-145.75M11.84M-13.12M58.62M-6.34M19.07M68.90M-4.37M-26.48M2.30M-47.30M11.94M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)
0.69M0.94M9.63M3.35M4.12M2.93M0.30M-2.03M199.88M-0.02M-7.35M-6.41M-6.65M-7.21M-4.99M-6.89M-6.42M-8.32M64.14M-7.29M
Additional items
Change in Cash (Quarter)
-72.53M52.60M41.86M-58.08M-9.26M15.63M-1.77M30.95M22.00M-9.79M-45.45M23.61M-27.77M1.46M47.12M-24.74M-15.40M-12.51M5.14M-2.51M
Free Cash Flow (Quarter)
-29.20M-21.75M-13.32M-26.77M-29.85M-16.06M-38.80M-16.17M-34.28M-22.97M-25.77M-30.27M-18.74M-21.93M-25.55M-16.03M27.39M-17.99M-11.84M-7.17M
Net Cash Flow (Quarter)
-72.53M52.60M41.86M-58.08M-9.26M15.63M-1.77M30.95M22.00M-9.79M-45.45M23.61M-27.77M1.46M47.12M-24.74M-15.40M-12.51M5.14M-2.51M